908 Devices Inc. (MASS) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to loss of $0.23 per share a year ago.
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today reported financial results for the quarter and full year
WALTHAM, Mass., & BOSTON--(BUSINESS WIRE)--Repligen Corporation (Nasdaq: RGEN), a life sciences company focused on bioprocessing technology leadership, and 908 Devices Inc. (Nasdaq: MASS), a pioneer i
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today announced it will participate in the following investor c
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of handheld and desktop devices for chemical analysis, today announced it will report financial results for the fourth quarter and f

Masivo's Clarification News Release per CIRO

02:13pm, Friday, 28'th Feb 2025
Vancouver, British Columbia--(Newsfile Corp. - February 28, 2025) - Masivo Silver Corp. (TSXV: MASS) (OTC Pink: GNYPF) ( " Masivo " or the " Company " ). Per Masivos communication with CIRO, they ha
Vancouver, British Columbia--(Newsfile Corp. - February 26, 2025) - Masivo Silver Corp. (TSXV: MASS) (OTC Pink: GNYPF) ("Masivo" or the "Company") is pleased to announce the signing of an LOI to acqui
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today announced preliminary unaudited financial results for the
BOSTON--(BUSINESS WIRE)-- #automation--Today, 908 Devices Inc. (Nasdaq: MASS) and Getinge announce their collaboration to integrate Getinge's bioreactors with 908 Devices' MAVEN for automated control
Vancouver, British Columbia--(Newsfile Corp. - December 10, 2024) - Masivo Silver Corp. (TSXV: MASS) (OTC Pink: GNYPF) ("Masivo" or the "Company") is pleased to announce that it has finished the dri
908 Devices Inc. (NASDAQ:MASS ) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET Company Participants Kelly Gura - Gilmartin Group Kevin Knopp - Chief Executive Officer and Co-Founder Joe
908 Devices Inc. (MASS) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to loss of $0.22 per share a year ago.
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today reported financial results for the quarter ended Septembe
Vancouver, British Columbia--(Newsfile Corp. - November 6, 2024) - Masivo Silver Corp. (TSXV: MASS) (OTC Pink: GNYPF) ("Masivo" or the "Company") is pleased to announce that it has finished the dril
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today announced it will participate in the following investor c
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE